CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors

Overview of attention for article published in Frontiers in oncology, December 2018

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter: 3 X users

patent: 1 patent

Citations

dimensions_citation: 162 Dimensions

Readers on

mendeley: 215 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

Pharmaceutical combination comprising TNO155 and ribociclib

Grant AU-2020222296-B2

Australia

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.